Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions?

Čubranić, Aleksandar; Dobrila-Dintinjana, Renata; Redžović, Arnela; Dintinjana, Marijan; Petranović, Duška; Golčić, Marin

doi:10.1016/j.mehy.2016.09.017

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, recombinant erythropoietin did not trigger increased proliferation of breast cancer cells, although they expressed EPO receptors [21]. It is plausible therefore, that although there are certain hints that EPO and its receptor correlate with tumor progression [22] there are doubts as for their activity as tumor promoters.…”

Section: Discussionmentioning

confidence: 99%

About The Interconnection Between Erythropoietin, Mononuclears And Colon Carcinoma Cells

Bessler¹,

Herman‐Edelstein²,

Djaldetti³

2018

IJHBD

View full text Add to dashboard Cite

Since centuries, medical practice has advanced concomitantly with newer therapeutic and research discoveries which improved markedly physicians' options for treating patients and to prolong human life. In that sense the short length of time from the assumption that there is a substance responsible for regulation of erythropoiesis and creation of human recombinant erythropoietin was amazing. During the seventies, one of the authors (MD) had the "privilege" to study various effects of human urinary erythropoietin which at those times was quite

show abstract

Section: Discussionmentioning

confidence: 99%